Latest bladder cancer Stories
Takeda Pharmaceutical Co. and Eli Lilly & Co. must pay a total of $9 billion in punitive damages after they were found to have concealed diabetes drug, Actos’, cancer risks.
A University of Colorado Cancer Center study published today in Journal of the National Cancer Institute (with related research being presented this weekend at the American Association for Cancer Research Annual Conference 2014) details the discovery of a new genetic driver of bladder cancer: silencing of the gene AGL.
New Pre-Clinical Data Presented at AACR Annual Meeting in San Diego SAN DIEGO, April 7, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Researchers in Italy say their review of studies on the link between selenium and malignancies like bladder cancer turned up too little evidence to support supplementation. Raleigh,
A University of Colorado Cancer Center study published today in Journal of the National Cancer Institute (with related research being presented this weekend at the American Association for Cancer
A new lawsuit filed on March 17, by a woman in Missouri Eastern District Court alleges that her father died from bladder cancer as a result of ingesting Actos.
A new UK report on the early warning signs of bladder cancer is especially relevant for diabetics and those who have taken Actos. Raleigh, NC (PRWEB) April 02,
Bladder cancer patients with metabolic syndrome – a set of conditions closely related to diabetes risk – are more likely to have a more invasive and fast-growing form of the disease.
A new study finds that a drug that kills bladder cancer cells with light works even better when another compound is added. Raleigh, NC (PRWEB) March 29, 2014
Nevada case involves allegations that women developed cancer as a result of Actos medication.
- A serpent whose bite was fabled to produce intense thirst.